CEFTRIAXONE injection, powder, for solution

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

CEFTRIAXONE SODIUM (UNII: 023Z5BR09K) (CEFTRIAXONE - UNII:75J73V1629)

Pieejams no:

A-S Medication Solutions

SNN (starptautisko nepatentēto nosaukumu):

CEFTRIAXONE SODIUM

Kompozīcija:

CEFTRIAXONE 500 mg

Ievadīšanas:

INTRAMUSCULAR

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

Before instituting treatment with Ceftriaxone for Injection, USP, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ceftriaxone for Injection, USP and other antibacterial drugs, Ceftriaxone for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ceftriaxone for Injection, USP is indicated for the treatment of the following infections when caused by susceptible organisms: LOWER RESPIRATORY TRACT INFECTIONS caused

Produktu pārskats:

Product: 50090-2628 NDC: 50090-2628-0 1 INJECTION, POWDER, FOR SOLUTION in a VIAL / 1 in a BOX

Autorizācija statuss:

Abbreviated New Drug Application

Produkta apraksts

CEFTRIAXONE- CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION
A-S MEDICATION SOLUTIONS
----------
CEFTRIAXONE FOR INJECTION, USP
RX ONLY
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of ceftriaxone for
injection and other antibacterial drugs, ceftriaxone for injection
should be used only to treat or prevent
infections that are proven or strongly suspected to be caused by
bacteria.
DESCRIPTION
Ceftriaxone for Injection, USP is a sterile, semisynthetic,
broad-spectrum cephalosporin antibiotic for
intravenous or intramuscular administration. Ceftriaxone sodium is
(6_R_,7_R_)-7-[2-(2-Amino-4-
thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-_as_-triazin-3-yl)thio]methyl]-
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7
-(_Z_)-(_O_-methyloxime), disodium salt,
sesquaterhydrate.
The chemical formula of ceftriaxone sodium is C
H N Na O S •3.5H O. It has a calculated
molecular weight of 661.59 and the following structural formula:
Ceftriaxone for Injection, USP is a white to yellowish-orange
crystalline powder which is readily
soluble in water, sparingly soluble in methanol and very slightly
soluble in ethanol. The pH of a 1%
aqueous solution is approximately 6.7. The color of Ceftriaxone for
Injection, USP solutions ranges
from light yellow to amber, depending on the length of storage,
concentration and diluent used.
Ceftriaxone for Injection, USP contains approximately 83 mg (3.6 mEq)
of sodium per gram of
ceftriaxone activity.
CLINICAL PHARMACOLOGY
Average plasma concentrations of ceftriaxone following a single
30-minute intravenous (IV) infusion of
a 0.5, 1 or 2 gm dose and intramuscular (IM) administration of a
single 0.5 (250 mg/mL or 350 mg/mL
concentrations) or 1 gm dose in healthy subjects are presented in
TABLE 1.
TABLE 1. CEFTRIAXONE PLASMA CONCENTRATIONS AFTER SINGLE
DOSE ADMINISTRATION
Dose/Route
Average Plasma Concentrations (mcg/mL)
0.5 hr 1 hr 2 hr 4 hr 6 hr 8 hr 12 hr 16 hr 24 hr
0.5 gm IV*
82
59
48
37
29
23
15
10
5
0.5 gm IM
250 mg/mL
2